Literature DB >> 4195791

L-dopa plus decarboxylase inhibitor in depression.

N Matussek, O Benkert, K Schneider, H Otten, H Pohlmeier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4195791     DOI： 10.1016/s0140-6736(70)91425-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 2.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

3.  The balance of biogenic amines as condition for normal behaviour.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

4.  [Biochemical research in depression (author's transl)].

Authors:  O Benkert
Journal:  Klin Wochenschr       Date:  1979-07-03

5.  Psychiatric aspects in Parkinsonism treated with L-dopa.

Authors:  A R Damãsio; J Lobo-Antunes; C Macedo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-10       Impact factor: 10.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.